Choose your preferred view mode

Please select whether you prefer to view the MDPI pages with a view tailored for mobile displays or to view the MDPI
pages in the normal scrollable desktop version. This selection will be stored into your cookies and used automatically
in next visits. You can also change the view style at any point from the main header when using the pages with your
mobile device.

Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington, CT 06030-1601, USAWebsite
| E-MailInterests: antigen presentation by MHC I and MHC II molecules; immune response to cancer; viral immunity and autoimmunity

Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, ItalyWebsite
| E-MailInterests: • role of miRNAs in the control of normal hematopoietic differentiation and in the development of leukemia; • induction of oxidative stress as a new strategy for the treatment of acute myeloid leukemias; circulating endothelial progenitors; • hypoxia-regulated miRNAs: their role in the control of normal and leukemic hematopoiesis; • molecular mechanisms controlling angiogenesis in myeloid neoplasiasSpecial Issues and Collections in MDPI journals:Special Issue: ncRNAs and Cancer Immunotherapy

Cellular Immunology Group, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, MSC-1750, Building 10, Room 8B08, Bethesda, MD 20892, USAE-MailInterests: the role of the human immune response to tumor-associated antigens. We are working to define and develop immunodominant determinants and modifications of those determinants toward the optimal activation of human immune responses to tumor-associated antigens. Additionally, we are involved in studying mechanisms to enhance the potency of antigen-presenting cells for specific T cell activation. We are also developing immunologic methods and immunoassays to better define the efficacy of vaccine therapies for a range of human cancers.Special Issues and Collections in MDPI journals:Special Issue: Immune Responses to Human Prostate Cancer